By successfully encapsulating a vaccine into a spider silk microparticle, Swiss and German researchers have discovered a novel technique that will help fight cancer and certain infectious diseases.
To fight cancer, researchers increasingly use vaccines that stimulate the immune system to identify and destroy tumour cells. However, the desired immune response is is not always guaranteed. In order to strengthen the efficacy of vaccines on the immune system – and in particular on T lymphocytes, specialized in the detection of cancer cells – researchers from the universities of Geneva (UNIGE), Freiburg (UNIFR), Munich, and Bayreuth, in collaboration with the German company AMSilk, have developed spider silk microcapsules capable of delivering the vaccine directly to the heart of immune cells. This process, published in the journal Biomaterials, could also be applied to preventive vaccines to protect against infectious diseases, and constitutes an important step towards vaccines that are stable, easy to use, and resistant to the most extreme storage conditions.
Our immune system is largely based on two types of cells: B lymphocytes, which produce the antibodies needed to defend against various infections, and T lymphocytes. In the case of cancer and certain infectious diseases such as tuberculosis, T lymphocytes need to be stimulated. However, their activation mechanism is more complex than that of B lymphocytes: to trigger a response, it is necessary to use a peptide, a small piece of protein which, if injected alone, is rapidly degraded by the body even before reaching its target.
“To develop immunotherapeutic drugs effective against cancer, it is essential to generate a significant response of T lymphocytes,» says Professor Carole Bourquin, a specialist in antitumor immunotherapies at the faculties of medicine and science of the UNIGE, who directed this work. “As the current vaccines have only limited action on T-cells, it is crucial to develop other vaccination procedures to overcome this issue.”
A virtually indestructible capsule
Scientists used synthetic spider silk biopolymers—a lightweight, biocompatible, non-toxic material that is highly resistant to degradation from light and heat. “We recreated this special silk in the lab to insert a peptide with vaccine properties,» explains Thomas Scheibel, a world specialist of spider silk from the University of Bayreuth who participated in the study. “The resulting protein chains are then salted out to form injectable microparticles.”
Silk microparticles form a transport capsule that protects the vaccine peptide from rapid degradation in the body, and delivers the peptide to the center of the lymph node cells, thereby considerably increasing T lymphocyte immune responses. “Our study has proved the validity of our technique”, reveals Carole Bourquin. “We have demonstrated the effectiveness of a new vaccination strategy that is extremely stable, easy to manufacture and easily customizable.”
Towards a new vaccine model
The synthetic silk biopolymer particles demonstrate a high resistance to heat, withstanding over 100°C for several hours without damage. In theory, this process would make it possible to develop vaccines that do not require adjuvants and cold chains. An undeniable advantage, especially in developing countries where one of the great difficulties is the preservation of vaccines. One of the limitations of this process, however, is the size of the microparticles: while the concept is in principle applicable to any peptide, which are all small enough to be incorporated into silk proteins, further research is needed to see if it is also possible to incorporate the larger antigens used in standard vaccines, especially against viral diseases.
When science imitates nature
“More and more, scientists are trying to imitate nature in what it does best”, adds Scheibel. “This approach even has a name: bioinspiration, which is exactly what we have done here.” The properties of spider silk make it a particularly interesting product: biocompatible, solid, thin, biodegradable, resistant to extreme conditions and even antibacterial, one can imagine multiple applications, including wound dressings or sutures.
Learn more: A new kind of vaccine based on spider silk
The Latest on: Vaccine delivery
via Google News
The Latest on: Vaccine delivery
- AP FACT CHECK: Trump Distorts Military Role in Vaccineson November 28, 2020 at 11:41 am
From the get-go, President Donald Trump has suggested that the military would be central in developing, producing and distributing vaccines for the pandemic ...
- Australia's Covid vaccines: everything you need to knowon November 28, 2020 at 11:14 am
Around the world about 200 Covid-19 candidate vaccines are being developed, with more than 40 in human clinical trial stage. The Australian government has agreements to secure four of the most ...
- COVID-19: A Basic Guide to Different Vaccine Types and How They Workon November 28, 2020 at 9:30 am
A look at how DNA and RNA vaccines work and how they train the immune system to fight SARS-CoV-2.
- Singapore's Co-Developed Vaccine Candidate Is in ‘Good Shape' for Delivery in 2021on November 26, 2020 at 8:47 pm
Positive results were announced by Singapore’s Covid vaccine candidate ARCT-021, developed by Arcturus Therapeutics together with Duke-NUS Medical School.
- Logmore Launches First Logistics Monitor Designed for COVID-19 Vaccine Deliveryon November 25, 2020 at 6:25 pm
Press Release Supply chain analytics solution provider Logmore has announced the launch of its latest product. Logmore Dry Ice, a high-spec version of Logmore's original data recorder, has been ...
- Today’s Logistics Report: Building Vaccine Supply Chains; Delivery’s Uphill Climb; Farming Looks Upon November 25, 2020 at 11:20 am
Today’s Top Supply Chain & Logistics News from WSJ.
- General: COVID-19 vaccines will be ready for delivery 24 hours after FDA authorizationon November 24, 2020 at 11:18 pm
Gustave Perna, who is leading Operation Warp Speed's effort to distribute coronavirus vaccines nationwide, told ABC News he is confident that vaccines will be "on the street" and headed to communities ...
- Vaccines Delivery Market Trends, Key Players, Manufacturers Data, Price Analysis, By Density Composition, By End User, By Region to 2026on November 23, 2020 at 4:47 pm
The report provides revenue of the global Vaccines Delivery market for the period 2016 and 2025, considering 2019 as ...
- A successful Ebola vaccine delivery shows how a Covid-19 vaccine would work in Africaon November 23, 2020 at 11:01 am
There have been growing concerns the very low-temperature requirements for the promising Covid-19 vaccine candidates developed by Pfizer and Moderna will lead to storage and logistics challenges that ...
via Bing News